Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic TDF/3TC/EFV FDC in Thai HIV Patients
NCT01160120Phase 2Completed
- Sponsor
- HIV-NAT
- Start
- Jun 2010
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir disoproxil fumarate, lamivudine, efavirenz in human immunodeficiency virus infection (HIV), sponsored by HIV-NAT. Started Jun 2010; status: completed.
02
Drugs
tenofovir disoproxil fumaratelamivudineefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01160120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01160120.